| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 293,419 | 277,957 | 267,513 | 305,091 | | Cost of Revenue | 91,903 | 80,632 | 76,083 | 85,082 | | | Gross Profit | 201,516 | 197,325 | 191,430 | 220,009 | | | Operating Expenses | | Research Development | 33,508 | 35,935 | 34,744 | 37,873 | | Selling General and Administrative | 93,273 | 94,370 | 96,076 | 108,475 | | Non Recurring | 3,626 | 11 | (10) | 109 | | Others | 3,804 | 3,756 | 3,723 | 3,707 | | | | Total Operating Expenses | 134,211 | 134,072 | 134,533 | 150,164 | | | | Operating Income or Loss | 70,914 | 63,253 | 56,897 | 69,845 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,558 | (208) | 2,176 | 3,957 | | Earnings Before Interest And Taxes | 68,863 | 63,045 | 59,073 | 73,846 | | Interest Expense | 9,680 | 3,865 | 11,077 | 9,266 | | Income Before Tax | 59,183 | 59,180 | 47,996 | 64,580 | | Income Tax Expense | 20,686 | 21,548 | 19,895 | 17,290 | | Minority Interest | 20 | (56) |
-
| 44 | | | | Net Income From Continuing Ops | 38,517 | 37,576 | 28,101 | 47,290 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,517 | 37,576 | 28,101 | 47,290 | | Preferred Stock And Other Adjustments |
-
| 16 | (16) |
-
| | | Net Income Applicable To Common Shares | $38,517 | $37,592 | $28,085 | $47,290 |
|
0.29% Nasdaq 0.00%
Income Statement
